Artificial Intelligence (AI) in Precision Medicine Market is expected to reach USD 10,244.52 million by 2032 | DelveInsight

DelveInsight's "Artificial Intelligence (AI) in Precision Medicine Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Artificial Intelligence (AI) in Precision Medicine companies actively working in the market.

According to DelveInsight's analysis, The AI in Precision Medicine market, valued at USD 1,036.91 million in 2024, is expected to grow at a compound annual growth rate (CAGR) of 33.18% between 2025 and 2032, reaching approximately USD 10,244.52 million by 2032. The Artificial Intelligence in Precision Medicine market is experiencing notable growth, largely due to the increasing global burden of chronic and genetic disorders, which has heightened the demand for personalized treatment approaches. This growth is further supported by the rising need for precision diagnostics and customized therapies, where AI excels at interpreting complex biological datasets. Ongoing technological advancements in AI-driven platforms, coupled with the development of innovative products, are improving the accuracy and efficiency of precision medicine solutions. Moreover, the market is benefiting from intensified research and development efforts and strategic product launches by leading AI in Precision Medicine companies. Together, these factors are expected to drive significant market expansion throughout the forecast period from 2025 to 2032.

To know more about why North America is leading the market growth in the Artificial Intelligence (AI) in Precision Medicine market, get a snapshot of the report Artificial Intelligence (AI) in Precision Medicine Market Trends - https://www.delveinsight.com/sample-request/ai-in-precision-medicine-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Artificial Intelligence (AI) in Precision Medicine Overview
Artificial Intelligence (AI) in Precision Medicine, also known as ear tubes or grommets, are small cylindrical devices inserted into the eardrum to allow air to enter the middle ear and prevent fluid buildup. They are commonly used to treat recurrent ear infections (otitis media) or persistent middle ear fluid (effusion) in children and adults. Artificial Intelligence (AI) in Precision Medicine help improve hearing, reduce the risk of infection, and relieve pressure or pain caused by fluid accumulation. The procedure to insert these tubes is called myringotomy and is typically quick and minimally invasive. The tubes often fall out on their own within 6 to 18 months.

Artificial Intelligence (AI) in Precision Medicine Market Insights
Geographically, North America is anticipated to hold the largest share of the Artificial Intelligence in Precision Medicine market throughout the 2025 to 2032 forecast period. This leadership is fueled by several key factors, including the increasing prevalence of chronic conditions such as cancer, lifestyle-related diseases like diabetes, and various infectious diseases. Furthermore, the region benefits from robust research and development initiatives focused on AI-driven precision medicine, a well-established healthcare system, and ongoing technological advancements in product innovation and regulatory approvals.

To read more about the latest highlights related to Artificial Intelligence (AI) in Precision Medicine, get a snapshot of the key highlights entailed in the Artificial Intelligence (AI) in Precision Medicine
https://www.delveinsight.com/report-store/ai-in-precision-medicine-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Recent Developments in the Artificial Intelligence (AI) in Precision Medicine Market Report
• In April 2025, Illumina Inc. and Tempus AI, Inc. have joined forces to advance the clinical adoption of next-generation sequencing tests. This partnership integrates Illumina's cutting-edge AI technologies with Tempus's comprehensive multimodal data platform to enhance genomic algorithm training and accelerate the application of molecular testing in clinical practice.
• In June 2024, Avicenna.AI, a prominent player in medical imaging AI, has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for CINA-VCF. This AI-powered triage and notification tool is designed to identify unsuspected vertebral compression fractures (VCFs) in patients receiving chest or abdominal CT scans.
• In March 2024, Bayer and Aignostics formed a partnership to drive the development of next-generation precision oncology. The collaboration will focus on jointly creating an innovative target identification platform that leverages multimodal patient data and advanced AI/ML technologies to improve the accuracy of cancer treatment.
• In June 2023, Illumina Inc., a global pioneer in DNA sequencing and array-based technologies, has introduced PrimateAI-3D, an advanced AI algorithm designed to predict disease-causing genetic mutations with exceptional accuracy. This innovation improves early detection of genetic risks and supports the development of more personalized treatment approaches.
• Thus, owing to such developments in the market, rapid growth will be observed in the Artificial Intelligence (AI) in Precision Medicine market during the forecast period

Key Players in the Artificial Intelligence (AI) in Precision Medicine Market
Some of the key market players operating in the Artificial Intelligence (AI) in Precision Medicine market include- TEMPUS, GE HealthCare, Qure.ai, Envisionit Deep AI (Pty) Ltd., Avicenna.AI, Aignostics, Inc., Proscia Inc., Ultivue, Inc., Prenosis, Inc., IBEX, Cleerly, Inc., Paige AI, Inc., Densitas® Inc., Photocure ASA, iCAD, Inc., Eko Health, Inc., Owkin, Inc, Massive Bio, Deep Bio Inc., Atomwise Inc., and others.

Which MedTech key players in the Artificial Intelligence (AI) in Precision Medicine market are set to emerge as the trendsetter explore @ Key Artificial Intelligence (AI) in Precision Medicine Companies - https://www.delveinsight.com/sample-request/ai-in-precision-medicine-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Analysis on the Artificial Intelligence (AI) in Precision Medicine Market Landscape
The increasing demand for personalized medicine and precision diagnostics is a key driver of growth in the Artificial Intelligence (AI) in Precision Medicine market. According to the Personalized Medicine Coalition (2024), the U.S. FDA approved 16 new personalized therapies for rare disease patients in 2023, a notable rise from six approvals in 2022. Of these approvals, seven were oncology treatments, while others addressed various diseases, highlighting the growing focus on tailored therapeutic solutions.

Additionally, the market is benefiting from intensified research and development (R&D) efforts and the launch of innovative products by major players in the industry. For instance, in June 2024, Tempus AI, Inc., a leading company in AI and precision medicine, received 510(k) clearance from the U.S. FDA for its Tempus ECG-AF. This AI-based tool assists in identifying patients at higher risk of atrial fibrillation/flutter (AF), allowing for earlier and more precise interventions.
Together, these factors are expected to drive substantial growth in the AI in Precision Medicine market during the forecast period from 2025 to 2032.

Scope of the Artificial Intelligence (AI) in Precision Medicine Market Report
• Coverage: Global
• Study Period: 2022-2032
• Artificial Intelligence (AI) in Precision Medicine Market Segmentation By Product Type: Hardware/Software and Services
• Artificial Intelligence (AI) in Precision Medicine Market Segmentation By Technology Type: Deep Learning, Natural Language Processing, and Machine Learning
• Artificial Intelligence (AI) in Precision Medicine Market Segmentation By Application Type: (Drug Discovery & Development and Disease Diagnostics), Therapeutic Area (Oncology, Cardiology, Neurology, Infectious Disease, Immunology, and Others
• Artificial Intelligence (AI) in Precision Medicine Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Artificial Intelligence (AI) in Precision Medicine Companies: TEMPUS, GE HealthCare, Qure.ai, Envisionit Deep AI (Pty) Ltd., Avicenna.AI, Aignostics, Inc., Proscia Inc., Ultivue, Inc., Prenosis, Inc., IBEX, Cleerly, Inc., Paige AI, Inc., Densitas® Inc., Photocure ASA, iCAD, Inc., Eko Health, Inc., Owkin, Inc, Massive Bio, Deep Bio Inc., Atomwise Inc., and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Artificial Intelligence (AI) in Precision Medicine market will grow by 2032? Click to get a snapshot of the Artificial Intelligence (AI) in Precision Medicine Market Analysis
https://www.delveinsight.com/sample-request/ai-in-precision-medicine-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.